SitesBLAST
Comparing WP_048098406.1 NCBI__GCF_000385565.1:WP_048098406.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
5d3mA Folate ecf transporter: amppnp bound state (see paper)
33% identity, 91% coverage: 9:242/258 of query aligns to 11:247/280 of 5d3mA
6mjpA Lptb(e163q)fgc from vibrio cholerae (see paper)
32% identity, 90% coverage: 6:238/258 of query aligns to 5:236/240 of 6mjpA
8bmsA Cryo-em structure of the mutant solitary ecf module 2eq in msp2n2 lipid nanodiscs in the atpase closed and atp-bound conformation (see paper)
32% identity, 91% coverage: 9:242/258 of query aligns to 10:244/278 of 8bmsA
- binding adenosine-5'-triphosphate: F12 (= F11), N39 (= N38), G40 (= G39), S41 (= S40), G42 (= G41), K43 (= K42), S44 (≠ T43), T45 (= T44), Q88 (vs. gap), Y133 (≠ L132), N140 (≠ E139), S142 (= S141), G143 (= G142), G144 (= G143), Q145 (= Q144), Q166 (≠ E165), H199 (= H197)
- binding magnesium ion: S44 (≠ T43), Q88 (vs. gap)
P07821 Iron(3+)-hydroxamate import ATP-binding protein FhuC; Ferric hydroxamate uptake protein C; Ferrichrome transport ATP-binding protein FhuC; Iron(III)-hydroxamate import ATP-binding protein FhuC; EC 7.2.2.16 from Escherichia coli (strain K12) (see 2 papers)
29% identity, 93% coverage: 8:248/258 of query aligns to 16:258/265 of P07821
- K50 (= K42) mutation to Q: Lack of activity.
- D172 (= D164) mutation to E: Lack of activity.
- E173 (= E165) mutation to A: Lack of activity.
4ymuJ Crystal structure of an amino acid abc transporter complex with arginines and atps (see paper)
33% identity, 86% coverage: 4:226/258 of query aligns to 2:224/240 of 4ymuJ
- binding adenosine-5'-triphosphate: F11 (≠ Y13), V16 (= V18), S36 (≠ N38), G37 (= G39), S38 (= S40), G39 (= G41), K40 (= K42), S41 (≠ T43), T42 (= T44), E162 (= E165), H194 (= H197)
- binding magnesium ion: S41 (≠ T43), E162 (= E165)
8bmpA Cryo-em structure of the folate-specific ecf transporter complex in msp2n2 lipid nanodiscs bound to atp and adp (see paper)
33% identity, 91% coverage: 9:242/258 of query aligns to 11:244/278 of 8bmpA
5x40A Structure of a cbio dimer bound with amppcp (see paper)
31% identity, 93% coverage: 4:242/258 of query aligns to 5:244/280 of 5x40A
- binding phosphomethylphosphonic acid adenylate ester: F14 (≠ Y13), V18 (≠ T17), A20 (≠ V18), N40 (= N38), G41 (= G39), G43 (= G41), K44 (= K42), S45 (≠ T43), T46 (= T44), Q88 (= Q82), H139 (≠ N138), M140 (≠ E139), L141 (= L140), S142 (= S141), G144 (= G143), Q145 (= Q144), Q166 (≠ E165), H198 (= H197)
- binding magnesium ion: S45 (≠ T43), Q88 (= Q82)
6s8nB Cryo-em structure of lptb2fgc in complex with lipopolysaccharide (see paper)
33% identity, 91% coverage: 4:238/258 of query aligns to 3:236/238 of 6s8nB
6s8gA Cryo-em structure of lptb2fgc in complex with amp-pnp (see paper)
33% identity, 91% coverage: 4:238/258 of query aligns to 3:236/238 of 6s8gA
- binding phosphoaminophosphonic acid-adenylate ester: Y12 (= Y13), R15 (≠ K16), N37 (= N38), G40 (= G41), K41 (= K42), T42 (= T43), T43 (= T44), Q84 (= Q82), S136 (≠ E139), S138 (= S141), E141 (≠ Q144)
6mhzA Vanadate trapped cryo-em structure of e.Coli lptb2fg transporter (see paper)
33% identity, 90% coverage: 4:235/258 of query aligns to 3:233/235 of 6mhzA
- binding adp orthovanadate: Y12 (= Y13), N37 (= N38), G38 (= G39), G40 (= G41), K41 (= K42), T42 (= T43), T43 (= T44), Q84 (= Q82), S136 (≠ E139), S138 (= S141), G139 (= G142), G140 (= G143), E162 (= E165), G166 (= G169), H194 (= H197)
6b8bA E. Coli lptb in complex with adp and a novobiocin derivative (see paper)
33% identity, 90% coverage: 4:235/258 of query aligns to 3:233/233 of 6b8bA
- binding adenosine-5'-diphosphate: Y12 (= Y13), R15 (≠ K16), V17 (= V18), G38 (= G39), G40 (= G41), K41 (= K42), T42 (= T43), T43 (= T44)
- binding (3s,5s,7s)-N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl}tricyclo[3.3.1.1~3,7~]decane-1-carboxamide: F89 (≠ S87), R90 (≠ S88), R91 (≠ N89)
6b89A E. Coli lptb in complex with adp and novobiocin (see paper)
33% identity, 90% coverage: 4:235/258 of query aligns to 3:233/234 of 6b89A
- binding adenosine-5'-diphosphate: Y12 (= Y13), R15 (≠ K16), V17 (= V18), N37 (= N38), G38 (= G39), G40 (= G41), K41 (= K42), T42 (= T43), T43 (= T44)
- binding magnesium ion: T42 (= T43), Q84 (= Q82)
- binding novobiocin: L71 (vs. gap), H72 (≠ R70), P83 (= P81), A86 (≠ E84), S87 (≠ H85), F89 (≠ S87), R90 (≠ S88), R91 (≠ N89), L92 (= L92), V101 (≠ G101), Q135 (≠ N138), R149 (= R152)
4p31A Crystal structure of a selenomethionine derivative of e. Coli lptb in complex with adp-magensium (see paper)
33% identity, 90% coverage: 4:235/258 of query aligns to 3:233/234 of 4p31A
6mbnA Lptb e163q in complex with atp (see paper)
33% identity, 91% coverage: 4:238/258 of query aligns to 4:237/241 of 6mbnA
1g291 Malk (see paper)
32% identity, 88% coverage: 1:226/258 of query aligns to 1:228/372 of 1g291
- binding magnesium ion: D69 (= D69), E71 (= E71), K72 (= K75), K79 (≠ Q82), D80 (≠ K83)
- binding pyrophosphate 2-: S38 (≠ N38), G39 (= G39), C40 (≠ S40), G41 (= G41), K42 (= K42), T43 (= T43), T44 (= T44)
Sites not aligning to the query:
Q99758 Phospholipid-transporting ATPase ABCA3; ABC-C transporter; ATP-binding cassette sub-family A member 3; ATP-binding cassette transporter 3; ATP-binding cassette 3; Xenobiotic-transporting ATPase ABCA3; EC 7.6.2.1; EC 7.6.2.2 from Homo sapiens (Human) (see 15 papers)
30% identity, 86% coverage: 16:237/258 of query aligns to 546:756/1704 of Q99758
- N568 (= N38) to D: in SMDP3; does not affect location in intracellular vesicle membrane; does not affect proteolytic cleavage; does not affect N-glycosylation; loss of ATP hydrolysis activity; decreases ATP binding in vitro; does not affect protein expression; does not affect multivesicular bodies and lamellar bodies location; affects multivesicular bodies and lamellar bodies development; loss of phosphatidylcholine transport; does not affect cholesterol transport; dbSNP:rs121909184
- L579 (≠ I49) to P: in SMDP3; uncertain significance
- R605 (≠ Q74) to Q: in SMDP3; uncertain significance; dbSNP:rs760006956
- S693 (≠ N168) mutation to L: Does not affect protein oligomerization.
Sites not aligning to the query:
- 43 R → L: in SMDP3; uncertain significance
- 53 N→Q: Does not affect N-glycosylation. Does not affect protein expression. Does not affect lamellar body membrane location.
- 101 L → P: in SMDP3; loss of intracellular vesicle membrane location; loss of proteolytic cleavage; does not affect N-glycosylation; loss of ATP hydrolysis activity; decreases ATP binding in vitro; dbSNP:rs121909182
- 124 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→Q: Loss of N-glycosylation. Reduces protein expression by 50%. Affects anterograde trafficking; when associated with Q-140. Reduces protein expression by 85%; when associated with Q-140. Does not affect lamellar body membrane location.
- 140 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N → H: in dbSNP:rs45447801; N→Q: Loss of N-glycosylation. Reduces protein expression by 50%. Affects anterograde trafficking; when associated with Q-124. Reduces protein expression by 85%; when associated with Q-140. Does not affect lamellar body membrane location.
- 173:174 LK→AA: Loss of proteolytic processing.
- 174:175 Cleavage; by CTSL
- 215 Q → K: in SMDP3; loss of lamellar bodies membrane location; loss of proteolytic cleavage; increases cellular free cholesterol and phosphatidylcholine transport; loss of vesicles formation; increases free cholesterol induced cell death; loss of protein oligomerization; dbSNP:rs879159551
- 280 R → C: in SMDP3; uncertain significance; does not affect protein oligomerization; dbSNP:rs201299260
- 288 R → K: in SMDP3; uncertain significance; does not affect protein oligomerization; dbSNP:rs117603931
- 290 L → M: in a breast cancer sample; somatic mutation
- 292 E → V: in SMDP3; uncertain significance; does not affect lamellar bodies membrane location; does not affect proteolytic cleavage; affects lamellar bodies formation; does not affect cholesterol and phosphatidylcholine transport; decreases vesicles formation; does not affect free cholesterol induced cell death; dbSNP:rs149989682
- 766 P → S: in dbSNP:rs45592239
- 801 E → D: in a breast cancer sample; somatic mutation
- 945 N→Q: Does not affect lamellar body membrane location. Does not affect protein expression. Does not affect proteolytic processing.
- 982 L → P: in SMDP3; loss of intracellular vesicle membrane location; loss of proteolytic cleavage; does not affect N-glycosylation; dbSNP:rs1402761450
- 1069 H → Q: in a breast cancer sample; somatic mutation
- 1076 N → K: in SMDP3; uncertain significance; dbSNP:rs2093663770
- 1221 G → S: in SMDP3; does not affect intracellular vesicle membrane location; does not affect proteolytic cleavage; does not affect N-glycosylation; loss of ATP hydrolysis activity; G→A: Decreases ATP hydrolysis activity of 15% compared to the wild-type.; G→T: Decreases ATP hydrolysis activity of 36% compared to the wild-type.; G→V: Decreases ATP hydrolysis activity of 18% compared to the wild-type.
- 1302 G → E: in SMDP3; uncertain significance; dbSNP:rs2093657978
- 1388 K → N: in SMDP3; decreases phosphatidylcholine transport; increases protein abundance; does not affect folding in the endoplasmic reticulum; decreases proteolytic processing; affects lamellar bodies development; reduces free cholesterol transport
- 1553 L → P: in SMDP3; loss of intracellular vesicle membrane location; loss of proteolytic cleavage; does not affect N-glycosylation; dbSNP:rs121909183
- 1580 L → P: in SMDP3; does not affect location in intracellular vesicle membrane; does not affect proteolytic cleavage; does not affect N-glycosylation; loss of ATP hydrolysis activity; decreases ATP binding in vitro; affects the intracellular vesicles development; decreases phosphatidylcholine transport; L→A: Decreases ATP hydrolysis activity of 13% compared to the wild-type.; L→F: Decreases ATP hydrolysis activity of 13% compared to the wild-type.; L→V: Decreases ATP hydrolysis activity of 56% compared to the wild-type.
- 1591 Q → P: in SMDP3; loss of intracellular vesicle membrane location; loss of proteolytic cleavage; does not affect N-glycosylation; dbSNP:rs28936691
Q0P9C4 Protein glycosylation K; EC 7.5.2.5 from Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) (see 2 papers)
33% identity, 76% coverage: 8:202/258 of query aligns to 353:546/564 of Q0P9C4
- K388 (= K42) mutation to A: Reduced efficiency of the N-linked protein glycosylation pathway.
- S389 (≠ T43) mutation to A: Impaired N-linked protein glycosylation pathway.
- G488 (= G143) mutation to D: Impaired N-linked protein glycosylation pathway.
- R492 (= R147) mutation to C: No effect on the N-linked protein glycosylation pathway.
- L506 (= L161) mutation to A: Reduced efficiency of the N-linked protein glycosylation pathway.
- E510 (= E165) mutation to Q: Abolishes ATPase activity and strongly reduces translocation of lipid-linked oligosaccharide.
Sites not aligning to the query:
- 46:67 Important for stimulation of ATPase activity by lipid-linked oligosaccharides and subsequent translocation of lipid-linked oligosaccharides; SDFSYFDRNKYLISLKEYLNIP→GSSGSSGS: Abolishes stimulation of ATPase activity by lipid-linked oligosaccharide binding. Abolishes translocation of lipid-linked oligosaccharide.
- 50 Y→A: Abolishes stimulation of ATPase activity by lipid-linked oligosaccharide binding and decreases translocation of lipid-linked oligosaccharide; when associated with A-56 and A-63.
- 53:55 RNK→ANA: Abolishes stimulation of ATPase activity by lipid-linked oligosaccharide binding. Strongly decreases translocation of lipid-linked oligosaccharide.
- 56 Y→A: Abolishes stimulation of ATPase activity by lipid-linked oligosaccharide binding and decreases translocation of lipid-linked oligosaccharide; when associated with A-50 and A-63.
- 63 Y→A: Abolishes stimulation of ATPase activity by lipid-linked oligosaccharide binding and decreases translocation of lipid-linked oligosaccharide; when associated with A-50 and A-56.
- 86 R→A: Abolishes translocation of lipid-linked oligosaccharide; when associated with A-260; A-302 and A-309.
- 260 R→A: Abolishes translocation of lipid-linked oligosaccharide; when associated with A-86; A-302 and A-309.
- 302 R→A: Abolishes translocation of lipid-linked oligosaccharide; when associated with A-86; A-260 and A-309.
- 309 R→A: Abolishes translocation of lipid-linked oligosaccharide; when associated with A-86; A-260 and A-302.
P69874 Spermidine/putrescine import ATP-binding protein PotA; EC 7.6.2.11 from Escherichia coli (strain K12) (see 3 papers)
32% identity, 86% coverage: 12:234/258 of query aligns to 26:245/378 of P69874
- C26 (≠ A12) mutation to A: Lower ATPase activity and transport efficiency.
- F27 (≠ Y13) mutation to L: Lower ATPase activity and transport efficiency.
- F45 (= F31) mutation to L: Lower ATPase activity and transport efficiency.
- C54 (≠ S40) mutation to T: Loss of ATPase activity and transport.
- L60 (= L46) mutation to F: Lower ATPase activity and transport efficiency.
- L76 (≠ V62) mutation to P: Lower ATPase activity and transport efficiency.
- V135 (= V127) mutation to M: Loss of ATPase activity and transport.
- D172 (= D164) mutation to N: Loss of ATPase activity and transport.
Sites not aligning to the query:
- 276 C→A: Lower ATPase activity and transport efficiency.
- 297 mutation E->K,D: Lower ATPase activity and transport efficiency.; E→Q: Loss of ATPase activity and transport.
P68187 Maltose/maltodextrin import ATP-binding protein MalK; EC 7.5.2.1 from Escherichia coli (strain K12) (see 5 papers)
32% identity, 88% coverage: 1:226/258 of query aligns to 1:222/371 of P68187